Senior Analyst
Fransiska Liliani
Fransiska advises leading health companies on understanding and navigating the Indonesian market. She has broad experience mapping Indonesia’s political, regulatory and business landscapes to design and execute strategies aimed at achieving commercial success. Fransiska achieves this while enhancing access to innovative medicines and medical devices and ensuring sustainability in Indonesia’s healthcare financing. Her work includes fostering alliances between businesses, key government officials and non-governmental organizations to advance these policy objectives.
Fransiska is recognized as an expert in healthcare regulation in the Indo-Pacific. She brings broad experience in advocating for public-private partnerships and promoting pro-investment regulations gained through her tenure working in global pharmaceutical companies. Additionally, she possesses a deep understanding of the commercial facets of the healthcare industry, having spearheaded growth and market penetration initiatives for prominent health organizations as a management consultant.
Fransiska holds a master’s degree in biomedical sciences from the University of Tsukuba, Japan. She obtained her pharmacist license from the University of Indonesia, graduating at the top of her class.
Insights & News
Singapore Adds BEPS-Compliant Incentives Ahead of Global Minimum Tax Rate Implementation
The BGA Singapore Team Singapore Managing Director Nydia Ngiow, wrote an update to clients on …
Trump II: Understanding Policy Prospects under the Next U.S. President
The BGA Thailand Team Senior Adviser Dr. Thitinan Pongsudhirak, wrote an update to clients on …
Trump’s Return: Implications for Business in Vietnam
The BGA Vietnam Team Managing Director Nguyen Viet Ha wrote an update to clients on …